|
|
After 1 month
|
After 1 month
|
After 1 month
|
After 1 month
|
Test Value
|
|
|
No symptoms
|
No symptoms
|
Symptoms
|
Symptoms
|
|
|
|
N
|
%
|
N
|
%
|
p
|
Gender
|
Female
|
41
|
47.7
|
117
|
51.1
|
0.589
|
|
Male
|
45
|
52.3
|
112
|
48.9
|
|
Age
|
<65
|
78
|
90.7
|
192
|
83.8
|
0.121
|
|
≤65
|
8
|
9.3
|
37
|
16.2
|
|
Thorax CT
|
No
|
48
|
55.8
|
60
|
26.2
|
<0.001
|
|
Ground glass opacities
|
31
|
36.0
|
129
|
56.3
|
|
|
Ground glass opacities and thrombus
|
0
|
0.0
|
4
|
1.7
|
|
|
Consolidation
|
5
|
5.8
|
25
|
10.9
|
|
|
Consolidation + ground glass opacities
|
2
|
2.3
|
10
|
4.4
|
|
|
Nodular Infiltration
|
0
|
0.0
|
1
|
0.4
|
|
Chest X -rays
|
Normal
|
48
|
55.8
|
60
|
26.2
|
<0.001
|
|
Infiltration
|
38
|
44.2
|
169
|
73.8
|
|
Treatment
|
Favipiravir
|
45
|
52.3
|
140
|
61.1
|
0.004
|
|
Favipravir and Hidroksiklorokin
|
9
|
10.5
|
43
|
18.8
|
|
|
Hidroksiklorokin
|
32
|
37.2
|
46
|
20.1
|
|
Smoking Behavior
|
Non smoker
|
46
|
53.5
|
151
|
65.9
|
0.117
|
|
Ex smoker
|
17
|
19.8
|
36
|
15.7
|
|
|
Current Smoker
|
23
|
26.7
|
42
|
18.3
|
|
Treatment place
|
Hospital
|
8
|
9.3
|
86
|
37.6
|
0.001
|
|
Home
|
78
|
90.7
|
143
|
62.4
|
|
Comorbidities
|
No
|
68
|
79
|
114
|
49
|
<0.001
|
|
Yes
|
18
|
21
|
115
|
51
|
|